Stay updated on T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page.

Latest updates to the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedAdded Contacts/Locations, Study Design, and Study Status to the record history and updated to Revision: v3.5.4 (version 38) on 2026-05-15; the history also notes the prior revision v3.5.3 dated 2025-05-09.SummaryDifference0.7%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a software/display update rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision v3.5.2 has been added to the history, replacing the previous v3.5.0.SummaryDifference0.1%

- Check43 days agoChange DetectedThe new screenshot preserves the same version history content and structure; only visual/layout adjustments are visible.SummaryDifference0.1%

- Check65 days agoChange DetectedNew revision entry v3.5.0 added to the history, and revision v3.4.3 is removed.SummaryDifference0.1%

- Check79 days agoChange DetectedThe history now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd vs T-DM1 in High-risk HER2+ Breast Cancer Clinical Trial page.